Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic HR+/HER2- Breast Cancer

Clinical trial condition

Metastatic HR+/HER2- Breast Cancer

Explore clinical trials studying Metastatic HR+/HER2- Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Metastatic HR+/HER2- Breast Cancer trial results

Not Yet Recruiting

Rash & Diarrhea Prophylaxis With Capivasertib

NCT07426822

Conditions: Diarrhea, Exanthema, Metastatic HR+/HER2- Breast Cancer, +5 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer

NCT07086196

Conditions: Breast Diseases, Breast Neoplasms, Metastatic HR+/HER2- Breast Cancer, +4 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details